[Development of a new platform for testing antiviral drugs using coronavirus-infected human nasal mucosa organoids].
Human nasal mucosa organoids with SARS-CoV-2 infection can serve as platforms for screening and testing antiviral drugs, particularly those intended for nasal administration.
Authors
- Jinli Wei (ORCID: https://orcid.org/0000-0003-4612-8475)
- Jianbo Cao (ORCID: https://orcid.org/0000-0002-0859-1680)
- Min Zhou (ORCID: https://orcid.org/0000-0002-9711-8894)
- Hailin Zheng (ORCID: https://orcid.org/0000-0003-0247-1853)
- Gang Li (ORCID: https://orcid.org/0000-0002-5557-9502)
- Rong Liu (ORCID: https://orcid.org/0000-0001-7477-6520)
- Wei Wang (ORCID: https://orcid.org/0000-0002-3827-0474)
- Yifei Yu (ORCID: https://orcid.org/0009-0006-2986-1682)
Institutions
- Chinese Academy of Sciences (CN)
- Wuhan Institute of Virology (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-11-20
- DOI
- https://doi.org/10.12122/j.issn.1673-4254.2024.11.20
- Primary Topic
- Respiratory viral infections research
- Type
- article